Lupin gets inspection report from USFDA for Nagpur facility
Lupin said it has received an establishment inspection report (EIR) from the US health regulator post the inspection of its Nagpur facility. “The United States Food and Drug Administration (USFDA) conducted a pre-approval inspection for its Phenytoin Sodium Extended Release 100 mg capsules,” Lupin said in a filing to the stock exchange. The plant was inspected by USFDA in September 2018, the company added.
USFDA gives EIR on closure of inspection of an establishment that is the subject of an FDA or FDA-contracted inspection. Commenting on the development, Lupin MD Mr. Nilesh Gupta said, “The successful completion of the Nagpur facility inspection is a positive development as we continue our journey to meet and exceed international regulatory standards.”
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
GHKCU 50mg High Purity Peptide Not For Human Use
$78/UNIT FOB
2026-07-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
FDA delays proposal to ban formaldehyde in hair straighteners
-
Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?
-
FDA Releases New Resources for Food Traceability Final Rule Compliance
-
IFSAC Unveils 2021 Report: Diverse Food Sources Linked to Salmonellosis Cases
-
FDA to Nationwide Ban Brominated Vegetable Oil (BVO) in Food
-
FDA Issues Warning to Produce Importer for Non-Compliance
-
FDA Proposes Ban on Hair Relaxers Containing Formaldehyde
-
US FDA Issues Alert: High Lead Levels Detected in Baby Fruit Puree
Recommend Reading
-
Brazil Confirms 32 Methanol Poisoning Cases Linked to Contaminated Alcoholic Beverages
-
EFSA Evaluates Extended Use of Pasteurised Akkermansia muciniphila as a Novel Food
-
EFSA Confirms Safety of β-Amylase Produced from Barley for Food Manufacturing Use
-
EFSA Unable to Confirm Safety of Fusarium flavolapis Fungal Protein as a Novel Food
-
EU Officially Approves Rapeseed Oil as a Low-Risk Active Substance Until 2040
-
Coke market prices show strong performance in China
-
Supply Contraction Meets Weak Consumption—PCs Consolidate in Early May
-
Insufficient Demand for Cyclohexane in China, Weak Market Situation Persists
-
Premium Global Chemical Sourcing Requests (07-10May, 2026)
-
Weak demand leads to continuous decline in ammonium sulfate prices in China (9.5-9.11)